Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value
$6.12+0.82 (+15.47%)
Close on Nov 11, 2026Market cap $91.70MP/E –Yield –
Cumberland Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Cumberland Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -30.8%. For fiscal 2025 it was -6.3%, against -17.0% the year before. The highest annual figure on record is 1259.7% in fiscal 2012.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -6.3% | +10.7 |
| FY2024 | Dec 31, 2024 | -17.0% | +7.2 |
| FY2023 | Dec 31, 2023 | -24.2% | −10.6 |
| FY2022 | Dec 31, 2022 | -13.6% | +7.8 |
| FY2021 | Dec 31, 2021 | -21.3% | −4.3 |
| FY2020 | Dec 31, 2020 | -17.0% | +10.0 |
| FY2019 | Dec 31, 2019 | -27.0% | +11.1 |
| FY2018 | Dec 31, 2018 | -38.1% | −28.2 |
| FY2017 | Dec 31, 2017 | -9.9% | −5.6 |
| FY2016 | Dec 31, 2016 | -4.3% | −127.9 |
| FY2015 | Dec 31, 2015 | 123.5% | −469.6 |
| FY2014 | Dec 31, 2014 | 593.1% | +1068.3 |
| FY2013 | Dec 31, 2013 | -475.2% | −1734.9 |
| FY2012 | Dec 31, 2012 | 1259.7% | +1240.5 |
| FY2011 | Dec 31, 2011 | 19.3% | +5.1 |
| FY2010 | Dec 31, 2010 | 14.2% | +0.9 |
| FY2009 | Dec 31, 2009 | 13.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1898.7% | −1079.4 |
| Q1 FY2026 | Mar 31, 2026 | -34.3% | −45.3 |
| Q4 FY2025 | Dec 31, 2025 | -10.0% | +7.6 |
| Q3 FY2025 | Sep 30, 2025 | -23.7% | −5.1 |
| Q2 FY2025 | Jun 30, 2025 | -819.2% | −808.8 |
| Q1 FY2025 | Mar 31, 2025 | 11.0% | +33.0 |
| Q4 FY2024 | Dec 31, 2024 | -17.7% | +48.4 |
| Q3 FY2024 | Sep 30, 2024 | -18.6% | −0.1 |
| Q2 FY2024 | Jun 30, 2024 | -10.4% | −10.6 |
| Q1 FY2024 | Mar 31, 2024 | -22.0% | −5.4 |
| Q4 FY2023 | Dec 31, 2023 | -66.1% | −41.1 |
| Q3 FY2023 | Sep 30, 2023 | -18.5% | −16.0 |
| Q2 FY2023 | Jun 30, 2023 | 0.2% | +18.1 |
| Q1 FY2023 | Mar 31, 2023 | -16.6% | −5.0 |
| Q4 FY2022 | Dec 31, 2022 | -25.0% | +27.4 |
| Q3 FY2022 | Sep 30, 2022 | -2.5% | +16.8 |
| Q2 FY2022 | Jun 30, 2022 | -17.9% | −2.1 |
| Q1 FY2022 | Mar 31, 2022 | -11.6% | −8.5 |
| Q4 FY2021 | Dec 31, 2021 | -52.3% | −35.3 |
| Q3 FY2021 | Sep 30, 2021 | -19.4% | −6.3 |
| Q2 FY2021 | Jun 30, 2021 | -15.9% | +0.6 |
| Q1 FY2021 | Mar 31, 2021 | -3.1% | +19.1 |
| Q4 FY2020 | Dec 31, 2020 | -17.0% | +19.5 |
| Q3 FY2020 | Sep 30, 2020 | -13.1% | +33.0 |
| Q2 FY2020 | Jun 30, 2020 | -16.5% | −1.9 |
| Q1 FY2020 | Mar 31, 2020 | -22.2% | −7.0 |
| Q4 FY2019 | Dec 31, 2019 | -36.5% | −19.7 |
| Q3 FY2019 | Sep 30, 2019 | -46.1% | −24.8 |
| Q2 FY2019 | Jun 30, 2019 | -14.6% | −6.0 |
| Q1 FY2019 | Mar 31, 2019 | -15.2% | +13.4 |
| Q4 FY2018 | Dec 31, 2018 | -16.8% | −9.0 |
| Q3 FY2018 | Sep 30, 2018 | -21.3% | −13.8 |
| Q2 FY2018 | Jun 30, 2018 | -8.5% | +10.8 |
| Q1 FY2018 | Mar 31, 2018 | -28.6% | −21.7 |
| Q4 FY2017 | Dec 31, 2017 | -7.8% | +2.8 |
| Q3 FY2017 | Sep 30, 2017 | -7.5% | −9.0 |
| Q2 FY2017 | Jun 30, 2017 | -19.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -6.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -10.5% | – |
| Q3 FY2016 | Sep 30, 2016 | 1.5% | – |
See a number that looks wrong?